Article
Viking Therapeutics skyrockets 25% on positive results for experimental weight loss drug
Rating:
0.0
Views:
19
Likes:
1
Library:
1
Weight-loss drugs like Ozempic have fueled a rally in pharmaceutical stocks in 2024, as investors eye the strong adoption of GLP-1 drugs.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value